Rappler
With order from Duterte, FDA says COVID-19 vaccine can arrive in PH before April 2021
President Rodrigo Duterte has approved in principle the emergency use of COVID-19 vaccines, allowing the FDA to grant Emergency Use Authorization (EUA).
This EUA will reduce the vaccine approval processing time from six months to 21 days, a measure proposed by Health Secretary Francisco Duque III and vaccine czar Carlito Galvez Jr.
Duterte has also approved recommendations for the Philippines to enter into advance supply agreements and provide early payments to vaccine manufacturers.
The FDA is fast-tracking the approval process for at least three drug makers seeking to hold clinical trials in the Philippines.
About five drug makers intend to conduct coronavirus clinical trials in the Philippines.
Duterte has expressed openness to vaccines developed by Russia or China and aims to secure funds for the inoculation of the entire population.
Topics in this story
Explore more stories about these topics.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
President Rodrigo Duterte has approved the government's recommendation to provide advance payments to pharmaceutical companies for COVID-19 vaccines.
+1
Read more →
Health Undersecretary Maria Rosario Vergeire assured that the Philippine government can still procure COVID-19 vaccines from companies like Moderna, even if they have not conducted clinical trials in the country.
+1
Read more →
President Rodrigo Duterte urged Asia Pacific Economic Cooperation (APEC) member-states to ensure the unimpeded flow of COVID-19 vaccines and other essential supplies once they become available.
Read more →
At least five potential COVID-19 vaccine manufacturers have expressed interest in conducting clinical trials in the Philippines, including Sinovac, Sputnik V, Clover Biopharmaceuticals, and AstraZeneca.
Read more →
Russia can start producing COVID-19 vaccines for the Philippines as early as January 2021, contingent on the Philippines completing due diligence, signing an agreement, and finalizing procurement.
Read more →